Indicator summary: Leaning bullish (3 bullish, 2 bearish, 0 neutral). As of 2026-11-05, the close was $340.50: 13.8% above the 50-day average and 13.7% above the 200-day average, which is rising. RSI (14) is 77, overbought. MACD is bullish. The stock sits 94% of the way up its 52-week range of $249.04 to $345.89, on 1.8x its 20-day average volume.
| Indicator | Reading | Read |
|---|---|---|
| 50-day average | $299.31 | Price 13.8% above |
| 200-day average | $299.45 | Price 13.7% above, average rising |
| 50 vs 200-day | 50 below 200 | Death-cross alignment |
| RSI (14) | 77 | Overbought |
| MACD (12, 26, 9) | +11.43 vs +7.19 | Line above signal |
| 52-week range | $249.04 to $345.89 | 94% of the way up the range |
| Volume vs 20-day average | 1.8x | Heavy |
Base rates use PSA's own daily history since 1999; they describe the past, not a forecast.
As of 2026-11-05, PSA's 14-day RSI is 77, which is overbought (above 70). When it had RSI above 70 (591 days), it was higher 63 trading days later 63% of the time, median +3.1%.
Yes. PSA closed at $340.50 on 2026-11-05, 13.7% above its 200-day average of $299.45, which is rising. When it closed above its 200-day average (4,645 days), it was higher 63 trading days later 69% of the time, median +5.0%.
Yes. PSA closed at $340.50 on 2026-11-05, 13.8% above its 50-day average of $299.31. When it closed above its 50-day average (4,282 days), it was higher 63 trading days later 68% of the time, median +4.7%.
No cross in the last 10 trading days. As of 2026-11-05 the MACD line is +11.43 against a signal line of +7.19, so MACD is bullish.
Yes. At $340.50 it sits 94% of the way up its 52-week range of $249.04 to $345.89, 1.6% below the high.
Leaning bullish: 3 of 5 indicators are bullish and 2 bearish as of 2026-11-05 (the 50 and 200-day averages, their alignment, RSI and MACD). A rating summarises the chart; it is not a recommendation.
ŷRobot chart signal: Hold, from the chart signal model.
PSA analysis: AI score, fair value and forecast · Is it a bull or a bear market today? · All covered stocks
ŷRobot analysis is AI-generated and quality-gated; nothing here is investment advice.